Smruthi Organics Limited (BOM:540686)

India flag India · Delayed Price · Currency is INR
122.65
-3.70 (-2.93%)
At close: Mar 6, 2026
3.59%
Market Cap 1.35B
Revenue (ttm) 1.11B
Net Income (ttm) 45.89M
Shares Out 11.45M
EPS (ttm) 4.02
PE Ratio 29.40
Forward PE n/a
Dividend 1.50 (1.22%)
Ex-Dividend Date Jun 13, 2025
Volume 4,024
Average Volume 4,025
Open 126.35
Previous Close 126.35
Day's Range 121.25 - 128.40
52-Week Range 103.00 - 164.00
Beta -0.42
RSI 59.35
Earnings Date Feb 13, 2026

About Smruthi Organics

Smruthi Organics Limited manufactures and markets active pharmaceutical ingredient (API) products to India. The company provides API for cardiovascular that includes amlodipine besilate, losartan potassium, telmisartan, s - amlodipine besilate, s - amlodipine malelate, and valsartan; for anti diabetic, which comprises metformin HCL, vildagliptin, teneligliptin, and dapagliflozin; and for anti infectives that consists of ciprofloxacin HCL, diloxanide furoate, norfloxacin, and pefloxacin mesylate, as well as ticagrelor for anti platelets. It also... [Read more]

Industry Medicinal Chemicals and Botanical Products
Founded 1989
Employees 267
Stock Exchange Bombay Stock Exchange
Ticker Symbol 540686
Full Company Profile

Financial Performance

In fiscal year 2025, Smruthi Organics's revenue was 1.26 billion, a decrease of -1.28% compared to the previous year's 1.28 billion. Earnings were 35.63 million, a decrease of -0.76%.

Financial Statements

News

There is no news available yet.